Please login to the form below

Not currently logged in
Email:
Password:

Chugai appoints US CMO

Athos Gianella-Borradori has clinical experience at Novartis and Merck Serono

Japanese company Chugai Pharma has named Dr Athos Gianella-Borradori as chief medical officer of its US subsidiary.

Dr Gianella-Borradori was most recently chief medical officer at Norwegian firm Clavis Pharma having joined the company in 2010 from Merck Serono.

At Merck Serono he served as head of clinical development for small molecules in onco-haematology and his prior experience includes clinical roles across Europe at Novartis, Crucell, Bavarian Nordic and Cyclacel.

The appointment at Chugai Pharma marks Dr Gianella-Borradori's first US role. As chief medical officer he has responsibility for all clinical activity in the US and will participate in a leadership role on scientific and translational committees for its Tokyo-headquartered parent company.

He will also represent Chugai, in which Swiss pharma company Roche owns a majority stake, in its relationships with the US FDA, academia, clinical investigators and patient communities.

30th April 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics